MCRB

15.24

5.34% -0.86

Vorhandelsmarkt: 14.98 -0.26 -1.71%

Seres Therapeutics Inc (MCRB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$16.10

Offen:

$16.05

24-Stunden-Volumen:

112.11K

Relative Volume:

0.71

Marktkapitalisierung:

$133.42M

Einnahmen:

$123.24M

Nettoeinkommen (Verlust:

$136.00K

KGV:

-762.00

EPS:

-0.02

Netto-Cashflow:

$-148.99M

1W Leistung:

-11.24%

1M Leistung:

-25.98%

6M Leistung:

+58.26%

1J Leistung:

-7.29%

1-Tages-Spanne:

$15.08

$16.66

1-Wochen-Bereich:

$15.08

$17.40

52-Wochen-Spanne:

$6.53

$24.67

Seres Therapeutics Inc Stock (MCRB) Company Profile

Firmenname

Seres Therapeutics Inc

Sektor

Healthcare (1136)

Branche

Biotechnology (633)

Telefon

617 945 9626

Adresse

200 SIDNEY STREET, CAMBRIDGE, MA

Mitarbeiter

103

Twitter

@SeresTX

Nächster Verdiensttermin

2024-10-31

Neueste SEC-Einreichungen

MCRB's Discussions on Twitter

Vergleichen Sie MCRB mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MCRB Seres Therapeutics Inc	15.24	140.95M	123.24M	136.00K	-148.99M	-0.02
VRTX Vertex Pharmaceuticals Inc	426.00	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.25	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.07	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	826.28	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.23	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Seres Therapeutics Inc Stock (MCRB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-05-08	Herabstufung	Chardan Capital Markets	Buy → Neutral
2024-10-24	Herabstufung	JP Morgan	Neutral → Underweight
2023-06-26	Fortgesetzt	Oppenheimer	Outperform
2023-04-21	Eingeleitet	JP Morgan	Neutral
2021-07-23	Herabstufung	Goldman	Neutral → Sell
2021-05-18	Fortgesetzt	Goldman	Neutral
2021-03-05	Hochstufung	Chardan Capital Markets	Neutral → Buy
2020-09-18	Herabstufung	Chardan Capital Markets	Buy → Neutral
2020-08-18	Eingeleitet	Piper Sandler	Overweight
2020-08-11	Bestätigt	H.C. Wainwright	Buy
2020-08-11	Hochstufung	Jefferies	Hold → Buy
2019-04-30	Eingeleitet	Jefferies	Hold
2018-10-22	Eingeleitet	Chardan Capital Markets	Buy
2017-10-13	Eingeleitet	Oppenheimer	Outperform
2017-08-04	Bestätigt	H.C. Wainwright	Buy
2017-02-01	Bestätigt	FBR & Co.	Outperform
2016-08-12	Bestätigt	FBR Capital	Outperform
2016-08-01	Herabstufung	BofA/Merrill	Buy → Neutral
2016-08-01	Bestätigt	H.C. Wainwright	Buy
2016-07-29	Fortgesetzt	H.C. Wainwright	Buy
2016-03-30	Eingeleitet	FBR Capital	Outperform
2016-03-03	Eingeleitet	Guggenheim	Buy
2016-01-25	Eingeleitet	H.C. Wainwright	Buy
2015-10-22	Hochstufung	BofA/Merrill	Neutral → Buy
2015-07-22	Eingeleitet	Canaccord Genuity	Buy
2015-07-21	Eingeleitet	Goldman	Neutral
2015-07-21	Eingeleitet	Leerink Partners	Outperform

Alle ansehen

Seres Therapeutics Inc Aktie (MCRB) Neueste Nachrichten

Nov 03, 2025

Analyzing Seres Therapeutics Inc. with risk reward ratio chartsJuly 2025 EndofMonth & Reliable Volume Spike Trade Alerts - newser.com

Nov 03, 2025

Will Seres Therapeutics Inc. (1S90) stock extend growth storyTrade Ideas & Daily Stock Trend Reports - newser.com

Nov 03, 2025

Is Seres Therapeutics Inc. stock supported by innovation pipeline2025 Volatility Report & Daily Growth Stock Investment Tips - newser.com

Nov 03, 2025

How interest rate cuts could boost Seres Therapeutics Inc. stockJuly 2025 Patterns & AI Forecast Swing Trade Picks - newser.com

Nov 03, 2025

What market sentiment indicators show for Seres Therapeutics Inc. (1S90) stock2025 Market WrapUp & Accurate Buy Signal Alerts - newser.com

Nov 03, 2025

Can volume confirm reversal in Seres Therapeutics Inc.2025 Market Trends & Low Risk High Win Rate Stock Picks - newser.com

Nov 03, 2025

Will Seres Therapeutics Inc. stock split attract more investorsJuly 2025 Spike Watch & Reliable Price Action Trade Plans - newser.com

Nov 03, 2025

Is Seres Therapeutics Inc. stock a contrarian buy2025 Historical Comparison & Stepwise Swing Trade Plans - newser.com

Nov 03, 2025

Key metrics from Seres Therapeutics Inc.’s quarterly data2025 Market Trends & Weekly High Return Stock Forecasts - newser.com

Nov 03, 2025

Published on: 2025-11-03 00:21:05 - newser.com

Nov 03, 2025

Published on: 2025-11-02 23:51:16 - newser.com

Nov 03, 2025

Nov 02, 2025

Is Seres Therapeutics Inc. stock recession proof2025 Year in Review & Daily Stock Trend Reports - newser.com

Nov 02, 2025

Analyzing Seres Therapeutics Inc. with multi timeframe chartsDollar Strength & Risk Managed Investment Strategies - newser.com

Nov 02, 2025

Institutional scanner results for Seres Therapeutics Inc.July 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com

Nov 02, 2025

Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Below Fifty Day Moving AverageTime to Sell? - MarketBeat

Nov 02, 2025

Is Seres Therapeutics Inc. stock attractive for hedge fundsEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com

Nov 02, 2025

Backtesting results for Seres Therapeutics Inc. trading strategiesWeekly Profit Report & Safe Capital Growth Stock Tips - newser.com

Nov 02, 2025

Is Seres Therapeutics Inc. stock a buy on dipsPrice Action & Reliable Volume Spike Trade Alerts - newser.com

Nov 02, 2025

Nov 01, 2025

Seres Therapeutics (MCRB) to Release Earnings on Wednesday - MarketBeat

Nov 01, 2025

Published on: 2025-11-01 01:46:58 - newser.com

Nov 01, 2025

Oct 31, 2025

How Seres Therapeutics Inc. (1S90) stock moves on employment dataExit Point & Daily Stock Trend Reports - newser.com

Oct 31, 2025

Operating cash flow per share of Seres Therapeutics Inc – BX:MCRB - TradingView

Oct 31, 2025

Is Seres Therapeutics Inc. (1S90) stock a buy before earnings resultsWeekly Profit Analysis & AI Enhanced Trading Alerts - newser.com

Oct 31, 2025

Published on: 2025-10-31 04:08:39 - newser.com

Oct 31, 2025

News impact scoring models applied to Seres Therapeutics Inc.Quarterly Portfolio Summary & Long-Term Safe Investment Plans - newser.com

Oct 31, 2025

Oct 30, 2025